Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-30

FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (Rising Pharma Holdings, Inc.), a combination antihypertensive product containing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAPTOPRIL AND HYDROCHLOROTHIAZIDE (captopril and hydrochlorothiazide)

Snippet

SUPPL AP for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (CAPTOPRIL AND HYDROCHLOROTHIAZIDE)